We were proud to see our CTO, Dominik Lipka PhD Eng. join the panel discussion “mRNA Delivery Innovation” at the 2nd Annual Meeting of AMM yesterday.

Together with industry leaders from Cytiva, Cytonus Therapeutics, and Acuitas Therapeutics, the panel- moderated by Anna Rose Welch (Advancing RNA) – shared valuable insights on the future of delivery technologies and advancing mRNA therapeutics.

As a proud member of Alliance for mRNA Medicines, SyVento BioTech is committed to driving innovation in mRNA delivery and contributing to the global dialogue shaping the future of advanced medicines. The Annual Meeting continues to be a unique platform for collaboration, knowledge sharing, and fostering partnerships across the RNA community.

A big thank you to the organizers for bringing such an inspiring community together!